NCT07152002View on ClinicalTrials.gov

A Study of LY4064912 in Healthy Participants and With Overweight or Obesity

PHASE1RecruitingINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

August 28, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Overweight or ObesityHealthy
Interventions
DRUG

LY4064912

Administered SC

DRUG

LY4064912

Administered IV

DRUG

Placebo

Administered SC

DRUG

Placebo

Administered IV

Trial Locations (3)

78209

RECRUITING

ICON Early Phase Services, San Antonio

90720

NOT_YET_RECRUITING

Collaborative Neuroscience Network - CNS, Los Alamitos

138623

NOT_YET_RECRUITING

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY